ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,063,727 | +17.4% | 271,848 | -0.3% | 0.50% | +12.1% |
Q3 2022 | $2,609,000 | -18.9% | 272,617 | -31.5% | 0.45% | -18.4% |
Q2 2022 | $3,218,000 | -51.7% | 397,745 | +0.8% | 0.55% | -35.5% |
Q1 2022 | $6,666,000 | +3.0% | 394,443 | +31.0% | 0.85% | +24.6% |
Q4 2021 | $6,473,000 | +16.3% | 301,203 | +299.7% | 0.68% | +18.4% |
Q3 2021 | $5,566,000 | – | 75,362 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |